HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yihong Ye Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

11/2023Molecular Graph-Based Deep Learning Algorithm Facilitates an Imaging-Based Strategy for Rapid Discovery of Small Molecules Modulating Biomolecular Condensates.
1/2023Abnormal triaging of misfolded proteins by adult neuronal ceroid lipofuscinosis-associated DNAJC5/CSPĪ± mutants causes lipofuscin accumulation.
1/2018DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yihong Ye Research Topics

Disease

8Neoplasms (Cancer)
11/2023 - 02/2009
3Neurodegenerative Diseases (Neurodegenerative Disease)
11/2023 - 01/2018
3Tauopathies
09/2023 - 01/2021
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2006
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2011 - 02/2009
2COVID-19
01/2024 - 01/2022
2Parkinson Disease (Parkinson's Disease)
11/2023 - 01/2020
2Inflammation (Inflammations)
09/2023 - 08/2023
2Gliosis
09/2023 - 08/2023
2Starvation
01/2021 - 01/2018
2Multiple Myeloma
11/2010 - 02/2009
1Rheumatoid Arthritis
01/2023
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2023
1Infections
01/2022
1Disease Progression
01/2022
1Breakthrough Infections
01/2022
1Cicatrix (Scar)
01/2020
1Anemia
01/2020
1Carcinogenesis
11/2015
1Dystonia musculorum deformans type 1
07/2011
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
07/2011
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
09/2006

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
11/2023 - 09/2006
3SynucleinsIBA
11/2023 - 01/2020
3Carrier Proteins (Binding Protein)IBA
09/2023 - 01/2023
3IntegrinsIBA
09/2023 - 01/2021
3Bortezomib (Velcade)FDA Link
08/2011 - 02/2009
2Deubiquitinating EnzymesIBA
11/2023 - 09/2006
2UbiquitinIBA
01/2021 - 02/2009
2Valosin Containing ProteinIBA
01/2019 - 11/2016
21- (4- chlorophenyl)- 3- (3- (4- chlorophenyl)- 5,5- dimethyl- 1- (3- (5- nitrofuran- 2- yl)allyldienehydrazinocarbonylmethyl)- 2- oxoimidazolidin- 4- yl)- 1- hydroxyureaIBA
11/2016 - 11/2010
2ATPases Associated with Diverse Cellular ActivitiesIBA
07/2011 - 11/2010
2Ataxin-3IBA
07/2011 - 09/2006
2Proteasome InhibitorsIBA
11/2010 - 02/2009
2PresenilinsIBA
08/2007 - 05/2006
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2024
1ChaperoninsIBA
11/2023
1DNA-Binding Proteins (DNA Binding Protein)IBA
11/2023
1Green Fluorescent ProteinsIBA
01/2023
1palmitoyl-protein thioesteraseIBA
01/2023
1Auranofin (Ridaura)FDA Link
01/2023
1Cysteine (L-Cysteine)FDA Link
01/2023
1Glutamine (L-Glutamine)FDA Link
01/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2023
1LipofuscinIBA
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1StreptavidinIBA
01/2023
1Sirolimus (Rapamycin)FDA Link
01/2023
1Heavy Chain Fusion Regulatory Protein 1IBA
01/2023
1Small Interfering RNA (siRNA)IBA
01/2023
1bafilomycin A1IBA
01/2023
1ClusterinIBA
01/2023
1Lysosomal-Associated Membrane Protein 1IBA
01/2023
1Endosomal Sorting Complexes Required for TransportIBA
01/2023
1DNA TopoisomerasesIBA
01/2022
1VaccinesIBA
01/2022
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2022
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2022
1Protein AggregatesIBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1ClathrinIBA
01/2020
1Adenosine Triphosphatases (ATPase)IBA
11/2015
1AntioxidantsIBA
08/2011
1polyglutamineIBA
07/2011
1CalpainIBA
07/2011
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2009
1Flavin-Adenine Dinucleotide (FAD)IBA
05/2006

Therapy/Procedure

8Therapeutics
01/2024 - 02/2009